Table 1. Characteristics of pediatric and young adult (PAYA) cancer survivors diagnosed between 1973 and 2010 in the United States.
| Characteristic | |
| Age at diagnosis; n (%) | |
| 0–9 years | 12,000 (19) |
| 10–19 years | 13,245 (21) |
| 20–29 years | 39,302 (61) |
| Female; n (%) | 34,299 (53) |
| Race; n (%) | |
| White | 54,385 (84) |
| Black | 5,117 (7.9) |
| Other | 5,045 (7.8) |
| Primary cancer diagnosis; n (%) | |
| Brain or central nervous system | 5,889 (9.1) |
| Breasta | 1,959 (5.7) |
| Cervicala | 2,619 (7.6) |
| Head and neck | 1,437 (2.2) |
| Hodgkin lymphoma | 7,838 (12) |
| Non-Hodgkin lymphoma | 3,472 (5.4) |
| Leukemia | 6,676 (10) |
| Melanoma (cutaneous) | 6,778 (11) |
| Ovariana | 1,670 (4.9) |
| Sarcoma | 1,721 (2.8) |
| Testicularb | 6,523 (22) |
| Thyroid | 6,888 (11) |
| Other | 11,077 (17) |
| Radiation; n (%) | 19,780 (31) |
| Years of follow-up; median (IQR c ) | 17 (10–25) |
| Cumulative incidence of HPV-associated subsequent malignancies (95% confidence limits) | 0.71% (0.50%, 0.97%) |
| Age at diagnosis of HPV-associated subsequent malignancy; median (IQR) | 38 (32–46) |
a
Among females;
b
Among males;
c
Interquartile range.